Combining human and rat sequences in her-2 DNA vaccines blunts immune tolerance and drives antitumor immunity.
about
The Promise of Preventive Cancer VaccinesEvolution of animal models in cancer vaccine developmentEmbryonic Lethality in Homozygous Human Her-2 Transgenic Mice Due to Disruption of the Pds5b Gene.Cryotherapy with concurrent CpG oligonucleotide treatment controls local tumor recurrence and modulates HER2/neu immunity.In situ immunization via non-surgical ablation to prevent local and distant tumor recurrence.Identification of relevant conformational epitopes on the HER2 oncoprotein by using Large Fragment Phage Display (LFPD).Induction of HER2 Immunity in Outbred Domestic Cats by DNA Electrovaccination.Bovine herpesvirus 4-based vector delivering a hybrid rat/human HER-2 oncoantigen efficiently protects mice from autochthonous Her-2(+) mammary cancerPreclinical HER-2 Vaccines: From Rodent to Human HER-2Chimeric DNA Vaccines against ErbB2+ Carcinomas: From Mice to Humans.Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2.DNA vaccination against oncoantigens: A promise.Xenogene vaccination in the therapy of cancer.Efficacy of a Cancer Vaccine against ALK-Rearranged Lung Tumors.Tailoring DNA Vaccines: Designing Strategies Against HER2-Positive Cancers"Omics" and Immunologic Approaches to Optimizing Cure Rates in HER2-Positive Breast Carcinomas.Breast cancer vaccines delivered by dendritic cell-targeted lentivectors induce potent antitumor immune responses and protect mice from mammary tumor growth.IL-15 augments antitumoral activity of an ErbB2/HER2 cancer vaccine targeted to professional antigen-presenting cells.Novel EXO-T vaccine using polyclonal CD4 T cells armed with HER2-specific exosomes for HER2-positive breast cancer
P2860
Q26783742-F152E077-2F58-4AD6-971C-5DCF2678560AQ28080739-9603F344-5A0B-48F5-80F4-A86F3B8FE3ABQ30403182-1F24CB31-AC68-4575-840F-4A381DE65EBAQ34288183-56C87355-62D5-4C5E-B041-E5AA53E49A8AQ34475389-59A476DC-912F-4430-9A41-BE81478A6235Q34650345-17B3A783-24B2-410F-B57F-CC36A4EA3238Q35815995-697D5CC6-763D-4854-9940-577C60CDDEE9Q36821263-16ABA0B5-84CC-451D-9B5E-8A08F41A9512Q36914661-653BC1EE-C581-4ECA-A5BB-EF0FBFF05B78Q37137404-6FC53557-3661-4BA4-A111-B70B78AB9A5DQ37691212-B5D48699-478B-4E84-BFB7-A1EE5B3991B6Q38022032-DBAA7103-5FEB-47E2-AD7D-CF090247037DQ38229368-B9393832-558D-424A-BFD9-3838BCAD4273Q38831440-32245AB7-1A06-4F52-A963-BDD29D90D8F5Q40674386-B03A1690-587F-43A3-AEBA-C073392F7D26Q41820672-2F3CE3D0-3AA8-42BC-B58C-9E63CB9DBC19Q41936513-355BB7C7-7440-4C52-9D51-759C29EC49B0Q54530047-E96010B6-B2CE-499A-B02A-90A1E0579C7BQ58547842-A35158DE-D6D7-44D7-8E65-C11A77BD267D
P2860
Combining human and rat sequences in her-2 DNA vaccines blunts immune tolerance and drives antitumor immunity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Combining human and rat sequen ...... and drives antitumor immunity.
@en
Combining human and rat sequen ...... and drives antitumor immunity.
@nl
type
label
Combining human and rat sequen ...... and drives antitumor immunity.
@en
Combining human and rat sequen ...... and drives antitumor immunity.
@nl
prefLabel
Combining human and rat sequen ...... and drives antitumor immunity.
@en
Combining human and rat sequen ...... and drives antitumor immunity.
@nl
P2093
P2860
P1433
P1476
Combining human and rat sequen ...... and drives antitumor immunity.
@en
P2093
Augusto Amici
Elena Quaglino
Jennifer B Jacob
Joyce D Reyes
Marie P Piechocki
Olga Radkevich-Brown
Richard F Jones
Wei-Zen Wei
P2860
P304
P356
10.1158/0008-5472.CAN-09-2554
P407
P577
2010-01-01T00:00:00Z